Keith G. Watson - Concepedia

Author

Keith G. Watson

Walter and Eliza Hall Institute of Medical Research

Also Known As

K. G. W. Watson, K. G. WATSON, K. G. Watson, K. WATSON, KEITH G. WATSON, Keith G Watson, Keith G. Watson, Keith Watson, Watson, Keith G.

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Walter and Eliza Hall Institute of Medical Research Monash University The University of Melbourne La Trobe University Commonwealth Scientific and Industrial Research Organisation

About

Keith G. Watson is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.2K
2	Natural Sciences	13	16	567
3	Biochemistry	12	14	482
4	Engineering	7	7	161
5	Biomolecular Engineering	6	6	157

Keith G. Watson

Publications

Citations

H-Index

Page 1

	Year	Citations
Structure-guided design of a selective BCL-XL inhibitor Guillaume Lessène, Peter E. Czabotar, Brad E. Sleebs, Nature Chemical Biology Drug TargetMedicineRational Drug DesignPharmacotherapySelective Bcl-xl Inhibitor	2013	370
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity Zhi‐Fu Tao, Lisa Hasvold, Le Wang, ACS Medicinal Chemistry Letters	2014	328
Dimeric Zanamivir Conjugates with Various Linking Groups Are Potent, Long-Lasting Inhibitors of Influenza Neuraminidase Including H5N1 Avian Influenza Simon J. F. Macdonald, Rachel Cameron, Derek A. Demaine, Journal of Medicinal Chemistry Medicinal ChemistryMedicinePlaque Reduction AssaysAntiviral Drug DevelopmentDimeric Zanamivir Conjugates	2005	87
Stereoselective syntheses of ephedrine and related 2-aminoalcohols of high optical purity from protected cyanohydrins W. R. JACKSON, Howard A. Jacobs, Barry Matthews, Tetrahedron Letters Bioorganic ChemistryBiochemistryNatural SciencesMedicineStereoselective Syntheses	1990	85
Potent and Long-Acting Dimeric Inhibitors of Influenza Virus Neuraminidase Are Effective at a Once-Weekly Dosing Regimen Simon J. F. Macdonald, Keith G. Watson, Rachel Cameron, Antimicrobial Agents and Chemotherapy Medicinal ChemistryAntiviral CompoundMedicineAntiviral TherapyVirology	2004	80
Asymmetric syntheses of (+)-diltiazem hydrochloride Keith G. Watson, Yik M. Fung, Matthew Gredley, Journal of the Chemical Society Chemical Communications Asymmetric SynthesesEnantioselective SynthesisEngineeringBiochemistryMedicine	1990	71
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binder Renee N. Brown, Rachel Cameron, David K. Chalmers, Bioorganic & Medicinal Chemistry Letters Capsid BinderBioorganic ChemistryNatural SciencesMolecular BiologyEthyl Benzoate Group	2005	68
Trypanothione Reductase High-Throughput Screening Campaign Identifies Novel Classes of Inhibitors with Antiparasitic Activity Georgina A. Holloway, William N. Charman, Alan H. Fairlamb, Antimicrobial Agents and Chemotherapy Bioorganic ChemistryHit IdentificationAntiparasitic AgentLead IdentificationPharmacotherapy	2009	65
A different mechanism for the inhibition of the carboxyltransferase domain of acetyl-coenzyme A carboxylase by tepraloxydim Song Xiang, Matthew M. Callaghan, Keith G. Watson, Proceedings of the National Academy of Sciences	2009	65
Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-X<sub>L</sub> Brad E. Sleebs, W. Kersten, Sanji Kulasegaram, Journal of Medicinal Chemistry PharmacotherapyChemistryCancer BiologyPharmaceutical ChemistryTumor Biology	2013	64

Page 1